Newsroom
Sorted by: Latest
-
MasTec Announces the Appointment of Ati Modak as Vice President of Investor Relations
CORAL GABLES, Fla.--(BUSINESS WIRE)--MasTec, Inc. (NYSE: MTZ) today announced the appointment of Ati Modak as Vice President of Investor Relations, effective September 2026. Mr. Modak joins MasTec from Goldman Sachs, where he served as Vice President, Equity Research, Energy Services, covering companies across the traditional and new energy sectors. Prior to joining Goldman Sachs in 2019, he worked at Citi. Mr. Modak received his Bachelor of Engineering degree from PDEU in India and his M.B.A....
-
BXP to Present at the BofA Securities 2026 Global Real Estate Conference
BOSTON--(BUSINESS WIRE)--BXP, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that Owen Thomas – Chairman & CEO; Douglas Linde – President; and Michael LaBelle – Chief Financial Officer, will participate in and present at the BofA Securities 2026 Global Real Estate Conference, which will be held September 15-17, 2026, at Two Bryant Park Pavilion in New York City, New York. BXP expects to begin its presen...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Capgemini: Life insurers under pressure: 42% of consumers are confused and unconvinced by policies
PARIS & WINDSOR, Conn.--(BUSINESS WIRE)--The World Life Insurance Report 2027, conducted jointly by the Capgemini Research Institute and LIMRA, finds an industry facing a relevance challenge....
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Redwood Trust Announces Third Quarter 2026 Common and Preferred Dividends
MILL VALLEY, Calif.--(BUSINESS WIRE)--Redwood Trust, Inc. (NYSE: RWT; “Redwood” or the “Company”), a leader in expanding access to housing for homebuyers and renters, today announced that its Board of Directors (the “Board”) has declared third quarter 2026 common and preferred stock dividends.Common Stock DividendThe Board has authorized the declaration of a third quarter 2026 regular common stock dividend of $0.18 per share, unchanged from the second quarter of 2026. This marks the Company's 10...
-
One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie
PARIS--(BUSINESS WIRE)--One Biosciences receives funding to develop the first single-cell profiling diagnostic to inform treatment decisions in triple negative breast cancer...
-
BDC Report: $11 Billion in ‘Big Six’ Gas Pipeline Spending Drives 67% Surge in Pennsylvania Gas Utility Bills
HARRISBURG, Pa.--(BUSINESS WIRE)--67% increase in Pennsylvania gas utility bills driven by $11 billion in ‘Big Six’ gas pipeline spending, BDC Reports....